Market Cap 181.11M
Revenue (ttm) 0.00
Net Income (ttm) -11.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 219,900
Avg Vol 374,418
Day's Range N/A - N/A
Shares Out 116.85M
Stochastic %K 73%
Beta -0.09
Analysts Strong Buy
Price Target $3.00

Company Profile

Tiziana Life Sciences Ltd, a biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for use in the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It is also developing TZLS-501, a...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 20 7495 2379
Address:
14/15 Conduit Street, London, United Kingdom
Ic0gcds000
Ic0gcds000 Jun. 16 at 5:49 PM
$TLSA next leg up should be $2+
0 · Reply
rp6577
rp6577 Jun. 16 at 5:40 PM
$TLSA looks like we’ll break out fairly soon $XBI
0 · Reply
Benisback24
Benisback24 Jun. 16 at 12:27 AM
3 · Reply
ThinkYouCan
ThinkYouCan Jun. 16 at 12:22 AM
2 · Reply
electric101
electric101 Jun. 14 at 5:09 PM
0 · Reply
redsstocktwits
redsstocktwits Jun. 13 at 7:49 PM
$DJT I am basically AHEAD of wall street. 50% instinct and 50% due diligence HARD TO BEAT. Wall street can't pump the real important sector to accumulate cause THEY LIKE TO GET THEIR MONEY BACK out of GLOBALIST stock like $TLSA and others, wall street money are trap in China and the big globalist stock of the world... But using our brain we should be accumulating... Nationalist/Patriotic stocks that do great and will survive the wartime and after war BEST STOCK IS DJT. Nuclear energy stock and Hydrogen best stock to have the moment these war in the middle east escalate and oil fields/refinary starting to burn. Weed stock --- In wartime mode Americans will turn to weed to relax, fight stress, fight sleepless nights, overcome depression. Wall street will not promote this now cause THEY ARE TRAP and like to get out of the globalist stock they pump and now they are trap... With magical instinct I AM AHEAD OF WALL STREET. $PLUG $URG $UEC Bu
2 · Reply
prismmarketview
prismmarketview Jun. 13 at 6:35 PM
$TLSA https://prismmarketview.com/tiziana-rises-12-as-foralumab-ms-trial-expands-to-weill-cornell/
0 · Reply
ROCKETMANZ
ROCKETMANZ Jun. 13 at 5:09 PM
$TLSA $ACUT Tizzy and Accustem both looking super bullish today 🐂 📈🚀
0 · Reply
upsoon007
upsoon007 Jun. 13 at 5:03 PM
$URGN payday 💰😎 more bio gems with big days ahead: $OKYO $TLSA Both clinical stage. Both up nicely today as well. DYODD 👌🏻 💎
0 · Reply
upsoon007
upsoon007 Jun. 13 at 4:55 PM
$TLSA https://www.proactiveinvestors.co.uk/companies/news/1072967/tiziana-life-sciences-expands-phase-2-ms-trial-to-fifth-site-commences-patient-dosing-1072967.html
0 · Reply
Latest News on TLSA
Tiziana Life Sciences Announces Purchase of Shares by Chairman

May 12, 2025, 7:00 AM EDT - 5 weeks ago

Tiziana Life Sciences Announces Purchase of Shares by Chairman


Tiziana Life Sciences Appoints New Chief Executive Officer

Aug 19, 2024, 7:00 AM EDT - 10 months ago

Tiziana Life Sciences Appoints New Chief Executive Officer


Tiziana Life Sciences Granted FDA Fast Track Designation

Jul 24, 2024, 7:00 AM EDT - 11 months ago

Tiziana Life Sciences Granted FDA Fast Track Designation


Tiziana Receives $3.4 Million in Non-Dilutive Funding

Jun 28, 2024, 11:01 AM EDT - 1 year ago

Tiziana Receives $3.4 Million in Non-Dilutive Funding


Ic0gcds000
Ic0gcds000 Jun. 16 at 5:49 PM
$TLSA next leg up should be $2+
0 · Reply
rp6577
rp6577 Jun. 16 at 5:40 PM
$TLSA looks like we’ll break out fairly soon $XBI
0 · Reply
Benisback24
Benisback24 Jun. 16 at 12:27 AM
3 · Reply
ThinkYouCan
ThinkYouCan Jun. 16 at 12:22 AM
2 · Reply
electric101
electric101 Jun. 14 at 5:09 PM
0 · Reply
redsstocktwits
redsstocktwits Jun. 13 at 7:49 PM
$DJT I am basically AHEAD of wall street. 50% instinct and 50% due diligence HARD TO BEAT. Wall street can't pump the real important sector to accumulate cause THEY LIKE TO GET THEIR MONEY BACK out of GLOBALIST stock like $TLSA and others, wall street money are trap in China and the big globalist stock of the world... But using our brain we should be accumulating... Nationalist/Patriotic stocks that do great and will survive the wartime and after war BEST STOCK IS DJT. Nuclear energy stock and Hydrogen best stock to have the moment these war in the middle east escalate and oil fields/refinary starting to burn. Weed stock --- In wartime mode Americans will turn to weed to relax, fight stress, fight sleepless nights, overcome depression. Wall street will not promote this now cause THEY ARE TRAP and like to get out of the globalist stock they pump and now they are trap... With magical instinct I AM AHEAD OF WALL STREET. $PLUG $URG $UEC Bu
2 · Reply
prismmarketview
prismmarketview Jun. 13 at 6:35 PM
$TLSA https://prismmarketview.com/tiziana-rises-12-as-foralumab-ms-trial-expands-to-weill-cornell/
0 · Reply
ROCKETMANZ
ROCKETMANZ Jun. 13 at 5:09 PM
$TLSA $ACUT Tizzy and Accustem both looking super bullish today 🐂 📈🚀
0 · Reply
upsoon007
upsoon007 Jun. 13 at 5:03 PM
$URGN payday 💰😎 more bio gems with big days ahead: $OKYO $TLSA Both clinical stage. Both up nicely today as well. DYODD 👌🏻 💎
0 · Reply
upsoon007
upsoon007 Jun. 13 at 4:55 PM
$TLSA https://www.proactiveinvestors.co.uk/companies/news/1072967/tiziana-life-sciences-expands-phase-2-ms-trial-to-fifth-site-commences-patient-dosing-1072967.html
0 · Reply
BioRich
BioRich Jun. 13 at 4:36 PM
$TLSA Love when I mess up ticker symbols and find winners. Was looking for $TSLA (Tesla) and found this gem, $TLSA (Tiziana Life Sciences). I think Tiziana is the better buy at this point as they have just initiated Phase 2 trials for Multiple Sclerosis. Up 14% on a down day with impressive room to grow. Not all mistakes are bad. Follow/Subscribe for more suggestions and perspective. Would love to hear yours, too. That's how we find these gems and learn. Let's make some money. Cheers! $XBI $SPY $QQQ
2 · Reply
rp6577
rp6577 Jun. 13 at 4:21 PM
$TLSA Okyo and Tiziana are absolutely cooking these days 🔥
0 · Reply
LewisDaKat
LewisDaKat Jun. 13 at 3:25 PM
News out Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center https://marketwirenews.com/news-releases/tiziana-life-sciences-expands-phase-2-clinical-trial-4852564556510587.html $TLSA
0 · Reply
upsoon007
upsoon007 Jun. 13 at 2:55 PM
$TLSA $OKYO like this guy here 🤫😎 https://ir.tizianalifesciences.com/node/11926/html https://fintel.io/i/chernett-jorey-2492
0 · Reply
NSAR
NSAR Jun. 13 at 2:52 PM
$TLSA I bought before the news. I saw the reversal and higher premarket activity
0 · Reply
NSAR
NSAR Jun. 13 at 2:51 PM
0 · Reply
upsoon007
upsoon007 Jun. 13 at 2:44 PM
$URGN While waiting patiently for the move here, take a look at $TLSA, this has all the ingredients for a big, long run.
1 · Reply
Tradephoenix
Tradephoenix Jun. 13 at 2:36 PM
$TLSA fifth site evaluation has begun at the prestigious Weill Cornell Medicine Multiple Sclerosis Center in New York City https://ir.tizianalifesciences.com/news-releases/news-release-details/tiziana-life-sciences-expands-phase-2-clinical-trial-intranasal Remember: Yale University, Johns Hopkins University, Brigham and Women's Hospital, and the University of Massachusetts have already begun. News rich 6-12 months ahead
0 · Reply
stocksbuytrade
stocksbuytrade Jun. 13 at 2:32 PM
$TLSA silently building a position. 🤫
1 · Reply
rp6577
rp6577 Jun. 13 at 2:31 PM
$TLSA some kind of leak? A lot of movement on no news
1 · Reply
G101SPM
G101SPM Jun. 13 at 12:54 PM
$TLSA $1.51 bid. DAC $0.846 (8.14.23) EXIT $4.00. NEWS: Mr Elrifi's presentation will cover the recent clinical findings of Tiziana's lead drug candidate, intranasal foralumab. Foralumab is the first fully human anti-CD3 monoclonal antibody administered via the intranasal route. This novel, non-systemic approach is designed to engage regulatory T cells, promoting immune tolerance while minimizing systemic immune suppression. Immunomodulation by intranasal foralumab represents a novel avenue for the treatment of neuroinflammatory and neurodegenerative human diseases. Tiziana has an ongoing Phase 2 trial in non-active Secondary Progressive Multiple Sclerosis and is progressing towards opening a Phase 2 trial in early Alzheimer's Disease. note: Jorey Chernett (CEO Authentic4D & Clearpath) disclosed 5.01% passive stake.
0 · Reply
WHATABOUTSTOCKS
WHATABOUTSTOCKS Jun. 13 at 12:42 PM
$TLSA $3 target!!!
2 · Reply